Niagen Bioscience to Showcase Healthy Aging Science at East Coast IDEAS Conference — Niagen Bioscience, Inc.

Event summary

Niagen Bioscience (NASDAQ: NAGE) will present at the East Coast IDEAS Investor Conference on June 11, 2026, in New York.
CEO Rob Fried will deliver a presentation from 2:40 - 3:15 PM ET, livestreamed via Three Part Advisors' website.
CFO Ozan Pamir will host one-on-one meetings with institutional investors during the event.
Niagen Bioscience focuses on NAD+ science and healthy aging, with Tru Niagen as its leading consumer supplement.

The big picture

Niagen Bioscience's participation in the East Coast IDEAS Investor Conference underscores its strategic focus on engaging with investment professionals to highlight its leadership in NAD+ science. The company's emphasis on healthy aging aligns with broader industry trends toward longevity and preventive health solutions. With Tru Niagen as the top NAD+ boosting supplement in the U.S., Niagen Bioscience is positioning itself for continued growth in the competitive biotech and healthcare sectors.

What we're watching

Market Positioning: How Niagen Bioscience will leverage this conference to strengthen its position as a leader in NAD+ science and healthy aging.
Investor Sentiment: Whether the company's presentation will generate renewed interest from institutional investors.
Product Expansion: The pace at which Niagen Bioscience can scale its product portfolio beyond Tru Niagen.